Institut de Reserches Servier contracts Pangaea to provide biomarker discovery services

Barcelona, March 13th - Pangaea Oncology and Institut de Reserches Servier have signed a contract for Pangaea to provide biomarker discovery (drug profiling) services to Servier through 2017. Institut de Reserches Servier belongs to the French pharmaceutical multinational Servier, which has contracted Pangaea’s services since 2014 in the areas of patients recruitment for clinical trials, through the Dr. Rosell Oncology Institute, as a central laboratory for molecular diagnostics, and for biomarker discovery (drug profiling) services.

We use first and third party cookies to track your browsing habits on our website in order to provide you with better quality and security, and improve the services offered through this website. If users do not explicitly confirm that they consent to the installation of cookies but continue to browse our website, we will assume that they have agreed and we will inform them accordingly about the possibility of blocking or deleting any previously installed cookies by adjusting their browser settings. You can find out more about cookies in our "Cookie Policy".